These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 3552352)

  • 1. Guillain-Barré syndrome: an ultrastructural study of peripheral nerve in 65 patients.
    Brechenmacher C; Vital C; Deminiere C; Laurentjoye L; Castaing Y; Gbikpi-Benissan G; Cardinaud JP; Favarel-Garrigues JP
    Clin Neuropathol; 1987; 6(1):19-24. PubMed ID: 3552352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Widenings of the myelin lamellae in a typical Guillain-Barré syndrome.
    Vallat JM; Leboutet MJ; Jauberteau MO; Tabaraud F; Couratier P; Akani F
    Muscle Nerve; 1994 Apr; 17(4):378-80. PubMed ID: 8170482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic inflammatory demyelinating polyneuropathy.
    Rizzuto N; Simonati A
    Int J Tissue React; 1985; 7(6):521-6. PubMed ID: 4086221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relapsing inflammatory demyelinating polyneuropathy in a diabetic patient.
    Vital C; Dumas P; Latinville D; Dib M; Vital A; Brechenmacher C
    Acta Neuropathol; 1986; 71(1-2):94-9. PubMed ID: 3776479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune attack on the Schwann cell surface in acute inflammatory demyelinating polyneuropathy.
    Hafer-Macko CE; Sheikh KA; Li CY; Ho TW; Cornblath DR; McKhann GM; Asbury AK; Griffin JW
    Ann Neurol; 1996 May; 39(5):625-35. PubMed ID: 8619548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory demyelination in a patient with CMT1A.
    Vital A; Vital C; Lagueny A; Ferrer X; Ribière-Bachelier C; Latour P; Petry KG
    Muscle Nerve; 2003 Sep; 28(3):373-6. PubMed ID: 12929199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute inflammatory demyelinating polyneuropathy in a diabetic patient: predominance of vesicular disruption in myelin sheaths.
    Vital C; Brechenmacher C; Cardinaud JP; Manier G; Vital A; Mora B
    Acta Neuropathol; 1985; 67(3-4):337-40. PubMed ID: 4050349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro demyelination by serum antibody from patients with Guillain-Barré syndrome requires terminal complement complexes.
    Sawant-Mane S; Clark MB; Koski CL
    Ann Neurol; 1991 Apr; 29(4):397-404. PubMed ID: 1718212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guillain-Barré syndrome; results of direct immunofluorescent study.
    Ammoumi AA; Pertschuk L; Daras M; Rosen AD
    N Y State J Med; 1980 Aug; 80(9):1434-5. PubMed ID: 7012707
    [No Abstract]   [Full Text] [Related]  

  • 10. Nonviral intranuclear inclusions in a nerve biopsy: an ultrastructural study.
    Vallat JM; Leboutet MJ; Loubet A; Corvisier N; Dumas M
    Muscle Nerve; 1983 Feb; 6(2):167-9. PubMed ID: 6304509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The Guillain-Barré syndrome].
    Piradov MA; Lozhnikova SM; Sakharova AV; Liudkovskaia IG; Nikitin SS
    Arkh Patol; 1994; 56(5):73-9. PubMed ID: 7535047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathology of the Guillain-Barré syndrome.
    Prineas JW
    Ann Neurol; 1981; 9 Suppl():6-19. PubMed ID: 7224616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative, histological and ultrastructural studies of peripheral nerve in arteriosclerotic non-diabetic patients.
    Vital A; Vital C; Brechenmacher C; Serise JM; Callen S; Nicolau H; Videau J
    Clin Neuropathol; 1986; 5(5):224-9. PubMed ID: 3791729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Polyradiculoneuritis in a diabetic patient. Ultrastructural study of a biopsy of a peripheral nerve].
    Vital C; Leblanc M; Andrèbe E; Aubertin J; Castaing R
    Rev Neurol (Paris); 1976 Apr; 132(4):263-74. PubMed ID: 778969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A fulminant case of Guillain-Barré syndrome: topographic and fibre size related analysis of demyelinating changes.
    Kanda T; Hayashi H; Tanabe H; Tsubaki T; Oda M
    J Neurol Neurosurg Psychiatry; 1989 Jul; 52(7):857-64. PubMed ID: 2769280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Class II antigen expression and inflammatory cells in the Guillain-Barré syndrome.
    Pollard JD; Baverstock J; McLeod JG
    Ann Neurol; 1987 Apr; 21(4):337-41. PubMed ID: 3555282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathology of the motor-sensory axonal Guillain-Barré syndrome.
    Griffin JW; Li CY; Ho TW; Tian M; Gao CY; Xue P; Mishu B; Cornblath DR; Macko C; McKhann GM; Asbury AK
    Ann Neurol; 1996 Jan; 39(1):17-28. PubMed ID: 8572662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo demyelinating activity of sera from patients with Guillain-Barré syndrome.
    Saida T; Saida K; Lisak RP; Brown MJ; Silberberg DH; Asbury AK
    Ann Neurol; 1982 Jan; 11(1):69-75. PubMed ID: 7059130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polyradiculoneuropathy accompanying procainamide-induced lupus erythematosus: evidence for drug-induced enhanced sensitization to peripheral nerve myelin.
    Sahenk Z; Mendell JR; Rossio JL; Hurtubise P
    Ann Neurol; 1977 Apr; 1(4):378-84. PubMed ID: 617255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Guillain-Barré syndrome: morphological lesions and their relations with clinical manifestations].
    Said G
    Rev Neurol (Paris); 1996 May; 152(5):344-8. PubMed ID: 8881427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.